COLLA, Simona
 Distribuzione geografica
Continente #
NA - Nord America 357
EU - Europa 279
AS - Asia 176
AF - Africa 2
OC - Oceania 1
Totale 815
Nazione #
US - Stati Uniti d'America 351
CN - Cina 104
IE - Irlanda 92
SG - Singapore 63
IT - Italia 58
SE - Svezia 50
DE - Germania 32
FI - Finlandia 15
CA - Canada 6
CZ - Repubblica Ceca 6
UA - Ucraina 6
FR - Francia 4
GB - Regno Unito 4
IL - Israele 4
TR - Turchia 4
AT - Austria 3
BE - Belgio 2
CI - Costa d'Avorio 2
PT - Portogallo 2
AU - Australia 1
BG - Bulgaria 1
IN - India 1
LU - Lussemburgo 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 815
Città #
Chandler 112
Dublin 89
Singapore 51
Shanghai 35
Ashburn 31
Boardman 28
Parma 27
Beijing 19
Princeton 13
Bremen 9
Milan 9
Munich 9
Wilmington 9
Dearborn 8
Nanjing 7
Santa Clara 7
Bologna 5
Brno 5
Jacksonville 5
Kunming 5
San Mateo 5
Hefei 4
Houston 4
Izmir 4
Marseille 4
New York 4
Ottawa 4
Shenyang 4
Changsha 3
Des Moines 3
Hebei 3
Helsinki 3
Jiaxing 3
Lviv 3
Nanchang 3
Rho 3
Vienna 3
Woodbridge 3
Abidjan 2
Ann Arbor 2
Brussels 2
Frankfurt am Main 2
Hangzhou 2
Los Angeles 2
Pescara 2
San Giuliano Milanese 2
Sassuolo 2
Tel Aviv 2
Tianjin 2
Toronto 2
Washington 2
West Jordan 2
Zhengzhou 2
Baoding 1
Casoria 1
Chengdu 1
Chicago 1
Dallas 1
Düsseldorf 1
Eboli 1
Fairfield 1
Forest City 1
Geislingen an der Steige 1
Huizen 1
Kolkata 1
Luxembourg 1
Male Hostice 1
Manassas 1
Palermo 1
Perth 1
Redmond 1
Rockville 1
Seattle 1
Sofia 1
Taizhou 1
Turin 1
Viterbo 1
Waterford 1
Totale 601
Nome #
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 75
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome 72
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy 70
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 68
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 67
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome 65
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 54
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 54
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 53
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function 50
PAF promotes stemness and radioresistance of glioma stem cells 48
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer 41
RNA processing: A new player of genomic instability in multiple myeloma 41
Down-regulation of EZH2 expression in myelodysplastic syndromes 35
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4) 25
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma 15
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 9
Totale 842
Categoria #
all - tutte 3.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 2 4 7 4 2 8 7 1
2020/202116 0 1 0 10 1 0 1 0 1 1 1 0
2021/202264 7 0 0 0 2 0 1 5 11 6 1 31
2022/2023341 23 40 14 39 28 39 16 19 107 2 12 2
2023/2024174 9 8 3 4 12 20 39 6 10 15 13 35
2024/2025114 7 17 21 48 21 0 0 0 0 0 0 0
Totale 842